11th Migration Course on Epileptology
Comprehensive epileptology: current concepts and strategies
Hotel M in Belgrade, Serbia
15 - 19 June 2023
ILAE Curriculum Learning Objectives addressed by this course
- 1.1.1 Describe the major etiologies for epilepsy (i.e. structural, genetic, infectious, metabolic, immune, and neurodegenerative) (L1)
- 1.1.2 Describe the common structural etiologies
- 1.1.3 Describe the common genetic causes of epilepsy
- 1.2.1 Decide on which patients to do genetic testing (L2)
- 1.2.2 Decide what type of genetic testing to conduct (L3)
- 1.2.3 Interpret and apply the results of genetic testing accurately in the clinical context (L3)
- 1.3.1 Learn and recognize the seizure semiology and distinguish it from other non-epileptic manifestations
- 1.3.3 Extract semiology information from video recordings
- 1.3.4 Interpret semiological signs and symptoms allowing hypotheses on the localization of focal seizures
- 1.3.5 Interpret semiological signs and symptoms suggesting focal vs. generalized onset
- 1.4.10 Recognize and describe ictal patterns (L2)
- 1.4.7 Recognize and describe background activity and sleep patterns in all age groups (L2)
- 1.4.8 Recognize and distinguish artifacts and normal variants from abnormal EEG patterns, and take actions necessary for eliminating artifacts (L2)
- 1.4.9 Recognize and describe interictal abnormalities (L2)
- 1.5.4 Decide when to conduct specialized neuroimaging and which type
- 1.5.5 Interpret and apply the results of specialized neuroimaging accurately in the clinical context (L3)
- 1.7.3 Correctly diagnose and classify focal epilepsies (L2)
- 1.7.4 Correctly diagnose and classify generalized epilepsies (L1)
- 1.8.1 Describe the epidemiology, psychiatric and experiential risk factors of PNES (L1)
- 1.8.2 Recognize the semiology of PNES and the use of video-EEG procedures and suggestion techniques in the diagnosis of suspected PNES (L2)
- 2.1 Understand and address the culturally appropriate aspects and consequences of the diagnosis of epilepsy, including stigma
- 2.7.1 Provide information and explain to a patient the concept of sudden unexpected death in epilepsy patients (SUDEP) and advise on the associated risks (L1)
- 2.8.1 Identify and provide counseling on issues related to comorbidities (L2)
- 2.8.2 Identify and provide counseling on issues related to drug interactions (L2)
- 3.1.1 Identify the spectrum of action for antiepileptic drugs (L1)
- 3.1.2 Demonstrate knowledge of pharmacokinetics and pharmacodynamics (L1)
- 3.1.3 Demonstrate knowledge regarding the adverse effects of antiepileptic drugs (L1)
- 3.1.5 Demonstrate knowledge about drug interactions (e.g. enzyme induction, etc.) for AED/AED and AED/concomitant medication
- 3.2.3 Recommend individualized titrations of optimal dosing for patients including starting and discontinuing medication (L1)
- 3.7.1 Demonstrate knowledge of indications, limitations, and risks for vagal nerve stimulation and other neuromodulation techniques (L3)
- 4.1.1 Demonstrate working knowledge of indications for pre-surgical evaluation (L1)
- 4.4.1 Demonstrate working knowledge of etiologies amenable to surgical treatment and their prognoses in all age groups (L2)
- 4.5.1 Demonstrate ability to integrate information from multi-modal work-up and estimate risks and benefits of surgical therapy (L3)
- 5.2.1 Appropriately diagnose all types of convulsive status epilepticus (L1)
- 5.2.2 Appropriately diagnose all types of nonconvulsive status epilepticus including EEG interpretations
- 5.3.1 Appropriately manage all types of convulsive status epilepticus including EEG monitoring of treatment effect (L2)
- 5.3.2 Appropriately manage all types of nonconvulsive status epilepticus including EEG monitoring of treatment effect (L2)
- 7.3.1 Demonstrate awareness of animal models for focal and generalized epilepsies (L3)
Subscribe to the ILAE Newsletter
To subscribe, please click on the button below.
Please send me information about ILAE activities and other
information of interest to the epilepsy community